Last A$0.39 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 12:18 AM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

cryosite ltd (CTE) Snapshot

Open
A$0.39
Previous Close
A$0.39
Day High
A$0.39
Day Low
A$0.39
52 Week High
10/17/13 - A$0.69
52 Week Low
07/1/14 - A$0.34
Market Cap
18.0M
Average Volume 10 Days
4.4K
EPS TTM
A$0.02
Shares Outstanding
46.9M
EX-Date
03/17/14
P/E TM
17.6x
Dividend
A$0.02
Dividend Yield
3.90%
Current Stock Chart for CRYOSITE LTD (CTE)

Related News

No related news articles were found.

cryosite ltd (CTE) Related Businessweek News

No Related Businessweek News Found

cryosite ltd (CTE) Details

Cryosite Limited provides specialized outsourced biologistics-based services to clients in the clinical research, medical, pharmaceutical, veterinary, and biotechnology industries in Australia and New Zealand. It operates in two segments: Biological Services and Warehousing & Distribution Services. The Biological Services segment provides private cord blood, adult stem cell storage, and general biorepository management services. The Warehousing & Distribution Services segment offers clinical trials logistics services and the other distribution based services, including the importation and distribution of the products of the American Type Culture Collection and laboratory diagnostics products. The company was founded in 1999 and is based in South Granville, Australia.

35 Employees
Last Reported Date: 08/28/13
Founded in 1999

cryosite ltd (CTE) Top Compensated Officers

Acting Chief Executive Officer and Executive ...
Total Annual Compensation: A$173.5K
Chief Financial Officer and Group Financial C...
Total Annual Compensation: A$120.1K
Compensation as of Fiscal Year 2013.

cryosite ltd (CTE) Key Developments

Cryosite Limited Revised Earnings Guidance for the Full Year of 2014

Cryosite Limited has provided the market with an updated 2013-2014 profit guidance. As outlined in the market announcement of 23 December 2013 the financial performance of the company in the second half of the financial year has suffered from the company's decision to implement a long term business growth strategy by investing in a number of new development activities in both the biological services and warehousing and distribution segments. This business growth strategy has seen an investment in personnel with a strengthening of the management team across all segments of the business, as well as incurring significant one off costs in the implementation of this strategy. The company now expects that the full-year profit from continuing operations before income tax will be in the range of $500,000 to $600,000. This compares with the previous guidance of $800,000 to $1.0 million.

Gordon Milliken to Retire as Managing Director of Cryosite Limited, Effective April 9, 2014

Cryosite Limited announced the retirement of Managing Director, Gordon Milliken on the April 9, 2014.

Cryosite Limited Declares Interim Dividend for the Half Year Ended December 31, 2013, Payable on April 4, 2014

Cryosite Limited announced that on February 25, 2014, the directors declared an unfranked interim dividend of 0.5 cent per share to the holders of fully paid ordinary shares for the half year ended December 31, 2013, payable to shareholders on April 4, 2014, and will be paid to all shareholders on the register of members as at March 21, 2014. The ex dividend payment trading commences March 17, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTE:AU A$0.39 AUD 0.00

CTE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CTE.
View Industry Companies
 

Industry Analysis

CTE

Industry Average

Valuation CTE Industry Range
Price/Earnings 18.6x
Price/Sales 2.2x
Price/Book 3.0x
Price/Cash Flow 18.5x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRYOSITE LTD, please visit www.cryosite.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.